Search
for
Sort by
Research 19
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- The 5α-Recluctase System and Its Inhibitors
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- News in brief ???
- Human Osteoblast-Like Cells Express Predominantly Steroid 5α-Reductase Type 1
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- 9 Role of 5α-reductase in health and disease
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Clinical use of 5α-reductase inhibitors
- Novel inhibitors of 5α-reductase
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
- Extensive Challenges and Pending Advances in the Study of 5-Alpha-Reductase Isoenzymes. A Literature Review